Skip to content
The Policy VaultThe Policy Vault

NeulastaCigna

Radiation Syndrome (Hematopoietic Syndrome of Acute Radiation Syndrome)

Initial criteria

  • Approve for 1 month if the agent is prescribed by or in consultation with a physician who has expertise in treating acute radiation syndrome.

Approval duration

1 month